{"id":"https://genegraph.clinicalgenome.org/r/8709dced-32c9-480a-82be-1cd2ecacf34ev1.1","type":"EvidenceStrengthAssertion","dc:description":"*TSPAN12* was first reported in relation to exudative vitreoretinopathy in 2010 (Nikopoulos et al., PMID: 20159111; Poulter et al., PMID: 20159112). TSPAN12-related exudative vitreoretinopathy is an inherited blinding disorder caused by defects in the development of retinal vasculature. There is extensive variation in disease severity among patients, even between members of the same family. *TSPAN12* was further reported be associated with exudative vitreoretinopathy in a semidominant manner in 4 families in 2012 (Poulter et al., PMID: 22427576).\n\nSeven variants (missense, nonsense, frameshift, and canonical splicing) are included in this curation. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. The mechanism of pathogenicity appears to be loss of function.\n\nThis gene-disease association is also supported by animal models and TSPAN12 protein being a part of the Norrin-LRP5-FZD4 signaling complex.\n\nIn summary, *TSPAN12* is definitively associated with autosomal dominant or more appropriately semidominant TSPAN12-related exudative vitreoretinopathy. This has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time. This classification was approved by the Retina GCEP on January 6th, 2022 (SOP Version 8).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/8709dced-32c9-480a-82be-1cd2ecacf34e","GCISnapshot":"https://genegraph.clinicalgenome.org/r/9c7915a6-c4eb-47c7-9c51-a81279b6e6a4","calculatedEvidenceStrength":"Definitive","changes":{"id":"cg:summaryChange"},"contributions":[{"id":"https://genegraph.clinicalgenome.org/r/9c7915a6-c4eb-47c7-9c51-a81279b6e6a4_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10072","date":"2024-06-29T04:22:13.290Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/9c7915a6-c4eb-47c7-9c51-a81279b6e6a4_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10072","date":"2022-01-06T17:00:00.000Z","role":"Approver"}],"curationReasons":["DiseaseNameUpdate"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9c7915a6-c4eb-47c7-9c51-a81279b6e6a4_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9c7915a6-c4eb-47c7-9c51-a81279b6e6a4_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7e418e62-b7c7-4eed-aa9c-a53cbf57cc74","type":"EvidenceLine","dc:description":"Also supported by genetic interaction, as shown by compound heterozygous mouse models of Tspan12+/-;Lrp5+/- or Tspan12+/-;Norrin+/- (Figure 3).","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5179ba68-7d67-4994-9bdc-24a9573e42ca","type":"Finding","dc:description":"TSPAN12 is a component of the Norrin-LRP5-FZD4 signaling complex. FZD4 (MIM 604579, dominant) is also associated with Familial exudative vitreoretinopathy (FEVR).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19837033","rdfs:label":"co-IP","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/9c7915a6-c4eb-47c7-9c51-a81279b6e6a4_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d0258216-af04-46d4-99aa-4c98d777b447","type":"EvidenceLine","dc:description":"Not scored because a previous mouse model has been scored.","calculatedScore":2,"direction":"Inconclusive","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/67263e44-8d6a-405c-acbd-eee1ef5ffdd0","type":"Finding","dc:description":"Early loss of TSPAN12 in endothelial cells causes lack of intraretinal capillaries and increased VE-cadherin (CDH5 [cadherin5 aka VE-cadherin]) expression, consistent with premature vascular quiescence.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30354230","rdfs:label":"conditional mouse model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/e4c81332-cc29-48d9-aeb2-a9923e7a37f4","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b5f94c5f-f504-41ee-9537-c2ffa3b38d59","type":"Finding","dc:description":"The  centrifugal outgrowth of  the NFL vasculature was  moderately delayed  in Tspan12-/- retinas (Figures 1C and 1D and data not shown) between P5 and P12. At  P11, vertical  sprouts  and  OPL  capillaries  appeared  in Tspan12+/+ mice,  whereas  both  were  completely  absent \n in Tspan12-/- mice. The Tspan12+/- mice also showed decreased retinal vertical sprouts (Figure 3B).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19837033","rdfs:label":"Mouse model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/9c7915a6-c4eb-47c7-9c51-a81279b6e6a4_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b7b8c161-86db-4d8b-bb5e-05fbf8ae848e_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b7b8c161-86db-4d8b-bb5e-05fbf8ae848e","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20159112","rdfs:label":"family2_Japan","allele":{"id":"https://genegraph.clinicalgenome.org/r/12a265ed-4331-4bc5-9629-ba7912a5dad4","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_012338.4(TSPAN12):c.419T>A (p.Leu140Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA251423"}},"firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Diagnosed in infancy with bilateral retinal folds. ","previousTesting":false,"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/df987bdb-0a03-4526-a9c4-60b65b44dd42_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20159112","allele":{"id":"https://genegraph.clinicalgenome.org/r/12a265ed-4331-4bc5-9629-ba7912a5dad4"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:MonoallelicHeterozygous"}},"zygosity":{"id":"cg:MonoallelicHeterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/df987bdb-0a03-4526-a9c4-60b65b44dd42","type":"EvidenceLine","dc:description":"absent in gnomAD, present in mildly-affected father.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/df987bdb-0a03-4526-a9c4-60b65b44dd42_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/a65e0ade-7ce1-4505-be2b-ca2e6bdb3f30_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a65e0ade-7ce1-4505-be2b-ca2e6bdb3f30","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20159112","rdfs:label":"family3_USA","allele":{"id":"https://genegraph.clinicalgenome.org/r/5796aa98-fba5-4b47-a7dd-1a1df3761c8e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_012338.4(TSPAN12):c.68T>G (p.Leu23Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA369141645"}},"firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"6-yr-old white female with bilateral retinal folds and unilateral, persistent hyperplastic primary vitreous (persistent fetal vasculature). ","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/26dbe14f-332a-4e54-b729-9246d501e0f5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20159112","allele":{"id":"https://genegraph.clinicalgenome.org/r/5796aa98-fba5-4b47-a7dd-1a1df3761c8e"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:MonoallelicHeterozygous"}},"zygosity":{"id":"cg:MonoallelicHeterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/26dbe14f-332a-4e54-b729-9246d501e0f5","type":"EvidenceLine","dc:description":"absent in gnomAD","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/26dbe14f-332a-4e54-b729-9246d501e0f5_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/9c7915a6-c4eb-47c7-9c51-a81279b6e6a4_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/74642c02-13ca-417c-80d9-e6a5f3d3d5f4_family_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20159111","rdfs:label":"family B","family":{"id":"https://genegraph.clinicalgenome.org/r/74642c02-13ca-417c-80d9-e6a5f3d3d5f4","type":"Family","rdfs:label":"family B","cg:modeOfInheritance":"Autosomal dominant/X-linked"},"meetsInclusionCriteria":true,"publishedLodScore":3.31,"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/27fa2602-b999-4385-90b8-617f0913eb96_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22427576","rdfs:label":"family HMH","family":{"id":"https://genegraph.clinicalgenome.org/r/27fa2602-b999-4385-90b8-617f0913eb96","type":"Family","rdfs:label":"family HMH","member":{"id":"https://genegraph.clinicalgenome.org/r/e6b4f14a-4e84-470e-acf3-b27d6d024da5","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22427576","rdfs:label":"III-1 (randomly assigned by curator)","allele":{"id":"https://genegraph.clinicalgenome.org/r/407f0d3c-6237-404a-b01f-df30c6ec9a22","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_012338.4(TSPAN12):c.413A>G (p.Tyr138Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA269452"}},"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/d7021803-aa07-415c-9a7f-05d0536661dd_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22427576","allele":{"id":"https://genegraph.clinicalgenome.org/r/407f0d3c-6237-404a-b01f-df30c6ec9a22"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:BiallelicHomozygous"}},"zygosity":{"id":"cg:BiallelicHomozygous"}},"cg:modeOfInheritance":"Semidominant"},"phenotypeFreeText":"Homozygotes presented in early childhood with tractional retinal detachments, whereas the heterozygous patients presented only with retinal exudates or peripheral avascularity.","proband":{"id":"https://genegraph.clinicalgenome.org/r/e6b4f14a-4e84-470e-acf3-b27d6d024da5"}},{"id":"https://genegraph.clinicalgenome.org/r/b602e925-1aec-4f6d-88a1-6c090fe3a80b_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20159111","rdfs:label":"Family A","family":{"id":"https://genegraph.clinicalgenome.org/r/b602e925-1aec-4f6d-88a1-6c090fe3a80b","type":"Family","rdfs:label":"Family A","member":{"id":"https://genegraph.clinicalgenome.org/r/bace9a0f-45c6-4ee6-90e9-5e839ac662f4","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20159111","rdfs:label":"III:7","allele":{"id":"https://genegraph.clinicalgenome.org/r/9a4da005-8a8d-4b04-8c09-4daff8525d42","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_012338.4(TSPAN12):c.709G>C (p.Ala237Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA251420"}},"detectionMethod":"Linkage analysis identified a target region on chr 7, the region was analyzed by NGS in family A & B. Sanger sequencing was used for confirmation and targeted analysis in family C & D.","firstTestingMethod":"Linkage analysis","previousTesting":false,"secondTestingMethod":"Next generation sequencing panels","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/f2b57339-0e79-44ba-bb19-7b3e94968421_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20159111","allele":{"id":"https://genegraph.clinicalgenome.org/r/9a4da005-8a8d-4b04-8c09-4daff8525d42"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:MonoallelicHeterozygous"}},"zygosity":{"id":"cg:MonoallelicHeterozygous"}},"cg:modeOfInheritance":"Autosomal dominant/X-linked"},"meetsInclusionCriteria":true,"proband":{"id":"https://genegraph.clinicalgenome.org/r/bace9a0f-45c6-4ee6-90e9-5e839ac662f4"},"publishedLodScore":2.34,"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/e1b72106-f6a5-4a47-9444-d9606a0e2647_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22427576","rdfs:label":"family TM","family":{"id":"https://genegraph.clinicalgenome.org/r/e1b72106-f6a5-4a47-9444-d9606a0e2647","type":"Family","rdfs:label":"family TM","member":{"id":"https://genegraph.clinicalgenome.org/r/51057ee1-b383-43dd-ad17-74d04894ce76","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22427576","rdfs:label":"IV-1","allele":{"id":"https://genegraph.clinicalgenome.org/r/588a7d1e-6690-4995-b2f7-47fc2df69229","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_012338.4(TSPAN12):c.67-1G>C","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA269453"}},"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/df7f524d-5ef5-41c8-bd71-80f2cfdae079_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22427576","allele":{"id":"https://genegraph.clinicalgenome.org/r/588a7d1e-6690-4995-b2f7-47fc2df69229"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:BiallelicHomozygous"}},"zygosity":{"id":"cg:BiallelicHomozygous"}},"cg:modeOfInheritance":"Semidominant"},"phenotypeFreeText":"The patient presented as a neonate with very poor vision and roving eye movements. Fundus examination revealed bilateral retinal folds, which remained stable through to the age of 6 years, when her latest examination documented a best corrected acuity of 1.5 LogMAR in each eye with myopia and astigmatism. The parents of the proband, although asymptomatic with normal visual function, had definite avascularity of the anterior retina bilaterally. One 19-year-old male cousin of the parents, was heterozygous for the c.67-1G>C variant,  had unilateral congenital visual loss (perception of light only) secondary to persistent hyperplastic vitreous (PHPV). The better-seeing right eye had 0.18 LogMAR acuity with a âˆ’10D myopic correction.","proband":{"id":"https://genegraph.clinicalgenome.org/r/51057ee1-b383-43dd-ad17-74d04894ce76"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/51057ee1-b383-43dd-ad17-74d04894ce76_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/51057ee1-b383-43dd-ad17-74d04894ce76"},{"id":"https://genegraph.clinicalgenome.org/r/df7f524d-5ef5-41c8-bd71-80f2cfdae079","type":"EvidenceLine","dc:description":"Reduced for consanguinity, absent in gnomAD","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/df7f524d-5ef5-41c8-bd71-80f2cfdae079_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/df7f524d-5ef5-41c8-bd71-80f2cfdae079_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Patient blood RNA analysis showed the variant caused exon skipping.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/bace9a0f-45c6-4ee6-90e9-5e839ac662f4_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bace9a0f-45c6-4ee6-90e9-5e839ac662f4"},{"id":"https://genegraph.clinicalgenome.org/r/f2b57339-0e79-44ba-bb19-7b3e94968421","type":"EvidenceLine","dc:description":"not found in gnomAD. Present in 2 big Dutch families (Figure 2A) and 2 smaller families (Figure S2). In total, there are 20 people with the variant and 18 people without the variant. ","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f2b57339-0e79-44ba-bb19-7b3e94968421_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/ea5ce870-2632-4228-90d6-48a4d0902253_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ea5ce870-2632-4228-90d6-48a4d0902253","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20159112","rdfs:label":"family1-proband","allele":{"id":"https://genegraph.clinicalgenome.org/r/b79bb09f-ed08-43b0-9bf6-939ca3356374","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_012338.4(TSPAN12):c.212_218dup (p.Phe73fs)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA251422"}},"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/3fbb2fad-2347-4cb5-8194-cc90fd3e03a7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20159112","allele":{"id":"https://genegraph.clinicalgenome.org/r/b79bb09f-ed08-43b0-9bf6-939ca3356374"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:MonoallelicHeterozygous"}},"zygosity":{"id":"cg:MonoallelicHeterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/3fbb2fad-2347-4cb5-8194-cc90fd3e03a7","type":"EvidenceLine","dc:description":"absent in gnomad. Present in asymptomatic father who is thought to have old exudative retinal detachments that have spontaneously resolved. Present in a 10-year old brother who did not undergo detailed eye examination.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3fbb2fad-2347-4cb5-8194-cc90fd3e03a7_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/e6b4f14a-4e84-470e-acf3-b27d6d024da5_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e6b4f14a-4e84-470e-acf3-b27d6d024da5"},{"id":"https://genegraph.clinicalgenome.org/r/d7021803-aa07-415c-9a7f-05d0536661dd","type":"EvidenceLine","dc:description":"gnomAD AF 0.00000406, consistent with mild-phenotype or non-penetrance.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d7021803-aa07-415c-9a7f-05d0536661dd_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/58448f16-9d22-4596-9746-fad10c5d7499_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/58448f16-9d22-4596-9746-fad10c5d7499","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20159112","rdfs:label":"UK","allele":{"id":"https://genegraph.clinicalgenome.org/r/243b58cb-2796-46ae-8625-dd128dc8a4cd","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_012338.4(TSPAN12):c.361-5_361-1del","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA251425"}},"firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"She has bilateral temporal retinal avascularity and associated areas of exudation visible with fundus fluorescein angiography. In addition, both eyes show traction of the retinal vasculature at the posterior pole.","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/399b259e-f596-4f24-a72d-d530ddc65573_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20159112","allele":{"id":"https://genegraph.clinicalgenome.org/r/243b58cb-2796-46ae-8625-dd128dc8a4cd"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:MonoallelicHeterozygous"}},"zygosity":{"id":"cg:MonoallelicHeterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/399b259e-f596-4f24-a72d-d530ddc65573","type":"EvidenceLine","dc:description":"Absent in gnomAD.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/399b259e-f596-4f24-a72d-d530ddc65573_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":8619,"specifiedBy":"GeneValidityCriteria8","strengthScore":15,"subject":{"id":"https://genegraph.clinicalgenome.org/r/NWnqEjix_HU","type":"GeneValidityProposition","disease":"obo:MONDO_0700231","gene":"hgnc:21641","modeOfInheritance":"obo:HP_0032113"},"version":"1.1","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_9c7915a6-c4eb-47c7-9c51-a81279b6e6a4-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}